Savarapharma
2 known investors
Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases. The company focuses on novel therapeutic approaches for patients with rare respiratory conditions.
BiotechHealthtechMedical Devices
Founders & leadership
MP
Matt PaulsChair of the Board of Directors and Chief Executive Officer